Immunodiagnostic Systems Hldgs PLC Transaction in Own Shares (3565R)

TIDMIDH

RNS Number : 3565R

Immunodiagnostic Systems Hldgs PLC

20 September 2017

Immunodiagnostic Systems Holdings plc

Transaction in Own Shares

20 September 2017

Immunodiagnostic Systems Holdings plc (IDH.L) ("IDS" or the "Company"), a specialist producer of manual and automated diagnostic testing kits and instrumentation for the clinical and research markets, announces that it has purchased (through Peel Hunt LLP acting as the Company's broker) the following number of its shares of 2p each on the London Stock Exchange. The purchased shares will be held as treasury shares.

The purchases were made pursuant to the buy-back programme announced on 21 June 2017.

 
 Date of purchase:                         20(th) September 
                                            2017 
 Number of shares purchased (aggregated 
  volume):                                 490 
 Highest price paid per share (pence):     310p 
 Lowest price paid per share (pence):      310p 
 Volume weighted average price paid 
  per share (pence):                       310p

Following the purchase of these shares, IDS holds 3,230 ordinary shares as treasury shares and the Company's issued share capital (excluding shares held as treasury shares) consists of 29,411,945 shares. All of the shares have equal voting rights. This figure 29,411,945 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), detailed information about the individual purchases made by Peel Hunt on the Company's behalf is set out in the schedule below.

For further information:

 
 Immunodiagnostic Systems     Tel : +44 (0)191 
  Holdings plc                 519 0660 
 Paul Martin, Group Finance 
  Director 
 
 
 Peel Hunt LLP                Tel : +44 (0)207 
                               418 8900 
 James Steel 
 Oliver Jackson

Schedule of Purchases - Individual Transactions

 
 Number of shares   Transaction price    Time of transaction   Trading venue 
  purchased          (pence per share) 
 490                310                  12:22:57              London Stock Exchange

This information is provided by RNS

The company news service from the London Stock Exchange

END

POSDBLFLDKFBBBV

(END) Dow Jones Newswires

September 20, 2017 13:09 ET (17:09 GMT)

Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Oct 2024 to Nov 2024